These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21688112)

  • 41. Mild cognitive impairment in Parkinson's disease.
    Martinez-Horta S; Kulisevsky J
    J Neural Transm (Vienna); 2019 Jul; 126(7):897-904. PubMed ID: 30963293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.
    Liebermann-Jordanidis H; Roheger M; Boosfeld L; Franklin J; Kalbe E
    J Parkinsons Dis; 2022; 12(6):1749-1782. PubMed ID: 35599499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort.
    Jones JD; Kuhn TP; Szymkowicz SM
    Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
    Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
    J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.
    King E; O'Brien J; Donaghy P; Williams-Gray CH; Lawson RA; Morris CM; Barnett N; Olsen K; Martin-Ruiz C; Burn D; Yarnall AJ; Taylor JP; Duncan G; Khoo TK; Thomas A
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1244-1250. PubMed ID: 30993722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild cognitive impairment in Parkinson's disease.
    Yarnall AJ; Rochester L; Burn DJ
    Age Ageing; 2013 Sep; 42(5):567-76. PubMed ID: 23868092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease.
    Jozwiak N; Postuma RB; Montplaisir J; Latreille V; Panisset M; Chouinard S; Bourgouin PA; Gagnon JF
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28645156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of awareness of hyposmia is associated with mild cognitive impairment in Parkinson's disease.
    Kawasaki I; Baba T; Takeda A; Mori E
    Parkinsonism Relat Disord; 2016 Jan; 22():74-9. PubMed ID: 26639980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current concepts in treating mild cognitive impairment in Parkinson's disease.
    Schneider JS; Kortagere S
    Neuropharmacology; 2022 Feb; 203():108880. PubMed ID: 34774549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.